Article Text

Download PDFPDF
Randomised controlled trial
Neither anti-inflammatory nor antibiotic treatment significantly shortens duration of cough in acute bronchitis compared with placebo
  1. John R Hurst,
  2. Aarash D Saleh
  1. UCL Respiratory Medicine, University College London, London, UK
  1. Correspondence to: Dr John R Hurst, UCL Respiratory Medicine, University College London, Royal Free Campus, London NW3 2PF, UK; j.hurst{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on:


Respiratory tract infections exert a significant burden on society through resultant school and employment absences and demand on primary care services. Most episodes are caused by respiratory viruses such as rhinovirus. Not only are there no effective antiviral drugs available to treat such infections, but our ability to manage their symptoms, especially cough, remains poor. Antibiotics are widely prescribed for acute bronchitis in primary care settings, even though their use demonstrates negligible effects on illness duration and correlates poorly with the presence of bacterial infection.1 ,2 Ineffective antibiotic use results in unnecessary cost and exposure for patients, and leads to greater bacterial resistance to antibiotics. Llor and colleagues hypothesise that airway inflammation in acute …

View Full Text


  • Competing interests None.